AbbVie posts 4Q loss on Shire deal breakup fee but adjusted results top expectations on Humira

Drugmaker Abbvie posted better-than-expected adjusted results for the fourth quarter on Friday due to double-digit growth of its blockbuster anti-inflammatory drug Humira.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.